Assembly Biosciences Participates in Three Investor Conferences

• Assembly Biosciences management will attend Guggenheim’s third Annual Healthcare Innovation Conference Nov. 10, 2026, with a fireside chat at 2 p.m. ET.
• A fireside chat at the UBS Global Biopharma Conference is scheduled for Nov. 16, 2026, at noon GMT.
• Management will also participate in the 2026 Jefferies Global Healthcare Conference in London on Nov. 17.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Assembly Biosciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611021600PRIMZONEFULLFEED9857368) on November 02, 2026, and is solely responsible for the information contained therein.